PAVM PAVmed Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: PAVM

Price (delayed)

$0.408

Market cap

$42.65M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.98

Enterprise value

$42.87M

PAVmed Inc. is a highly differentiated, multiproduct medical device company employing a unique business model designed to advance innovative products to commercialization much more rapidly and with significantly less capital ...

Highlights
PAVM's gross margin is up by 27% since the previous quarter
PAVmed's revenue has soared by 68% from the previous quarter but it has decreased by 8% YoY
The EPS has declined by 34% year-on-year but it is up by 2% since the previous quarter
The equity has dropped by 148% year-on-year and by 128% since the previous quarter
PAVM's quick ratio has dropped by 74% year-on-year
Sector: Healthcare
Industry: Medical Devices
Website: http://www.pavmed.com
Peers: PACB

Key stats

What are the main financial stats of PAVM
Market
Shares outstanding
104.53M
Market cap
$42.65M
Enterprise value
$42.87M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
62.48
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
67.62
Earnings
Revenue
$634,000
EBIT
-$88.59M
EBITDA
-$85.47M
Free cash flow
-$75M
Per share
EPS
-$0.98
Free cash flow per share
-$0.77
Book value per share
-$0.22
Revenue per share
$0.01
TBVPS
$0.64
Balance sheet
Total assets
$65.29M
Total liabilities
$54.48M
Debt
$49.5M
Equity
-$22.06M
Working capital
$3.3M
Liquidity
Debt to equity
-2.24
Current ratio
1.07
Quick ratio
0.98
Net debt/EBITDA
0
Margins
EBITDA margin
-13,481.5%
Gross margin
-624%
Net margin
-14,202.2%
Operating margin
-14,462.9%
Efficiency
Return on assets
-131.8%
Return on equity
N/A
Return on invested capital
-1,067.5%
Return on capital employed
-601%
Return on sales
-13,972.9%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

PAVM stock price

How has the PAVmed stock price performed over time
Intraday
3.95%
1 week
-8.85%
1 month
-12.88%
1 year
-59.6%
YTD
-15%
QTD
9.24%

Financial performance

How have PAVmed's revenue and profit performed over time
Revenue
$634,000
Gross profit
-$3.96M
Operating income
-$91.7M
Net income
-$90.04M
Gross margin
-624%
Net margin
-14,202.2%
The net margin has plunged by 69% YoY but it has grown by 40% from the previous quarter
PAVmed's revenue has soared by 68% from the previous quarter but it has decreased by 8% YoY
The net income has dropped by 56% year-on-year
The operating margin has dropped by 51% year-on-year but it rose by 40% since the previous quarter

Growth

What is PAVmed's growth rate over time

Valuation

What is PAVmed stock price valuation
P/E
N/A
P/B
N/A
P/S
62.48
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
67.62
The EPS has declined by 34% year-on-year but it is up by 2% since the previous quarter
The equity has dropped by 148% year-on-year and by 128% since the previous quarter
PAVmed's revenue has soared by 68% from the previous quarter but it has decreased by 8% YoY
The stock's price to sales (P/S) is 41% less than its last 4 quarters average of 106.3

Efficiency

How efficient is PAVmed business performance
The ROS has dropped by 67% year-on-year but it is up by 40% since the previous quarter
PAVM's return on assets is down by 48% year-on-year and by 8% since the previous quarter
The company's return on invested capital rose by 43% QoQ

Dividends

What is PAVM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PAVM.

Financial health

How did PAVmed financials performed over time
The total assets is 20% more than the total liabilities
The total liabilities has surged by 178% year-on-year and by 27% since the previous quarter
PAVmed's current ratio has shrunk by 74% YoY
The equity has dropped by 148% year-on-year and by 128% since the previous quarter
PAVM's debt to equity is up by 41% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.